drugset / Trial / NCT05886075
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Phase 0
Unknown
24 enrolled
Shanghai Yunying Medical Technology
The PLA Navy Anqing Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
24 participants are expected to be enrolled for this open，Single-armed clinical trial to evaluate the safety and efficacy of the recombinant herpes simplex virus Ⅰ, R130 in patients with relapsed/refractory advanced solid tumors.
Timeline
- Start
- 2023-03-30
- Primary completion
- 2025-03
- Completion
- 2025-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | R130 | Unknown | — | Other |